CliffBio
small molecule

SULFACETAMIDE SODIUM

SULFACETAMIDE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand nameSULFACETAMIDE SODIUM
Active ingredientSULFACETAMIDE SODIUM
Strength30%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalMay 1987
Marketing statusDISCN

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

SULFACETAMIDE SODIUM patent cliff — loss of exclusivity — | CliffBio